Nasdaq:US$15.35 (-0.49) | HKEX:HK$24.70 (-0.40) | AIM:£2.26 (-0.05)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 5 Nov 2009

Successful Global Phase IIb Ulcerative Colitis Trial for HMPL-004: All Primary and Secondary Endpoints Achieved Hutchison MediPharma Proceeding with Development and Partnership Plans

1 items
a091105